Position in EYPT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,586,195
+$294,337 QoQ
Shares Held
250,783
-1.8% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 188 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. EYPT ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in EYPT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,586,195 | 250,783 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $3,291,858 | 255,381 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,690,692 | 256,743 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,017,410 | 211,897 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,954,472 | 207,702 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,100,008 | 202,954 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,521,735 | 204,260 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,335,973 | 167,206 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,782,559 | 204,892 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,193,595 | 154,504 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $2,995,284 | 129,610 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $924,361 | 115,690 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $899,413 | 103,381 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $211,266 | 71,860 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $280,167 | 80,048 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $611,575 | 77,317 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $550,339 | 69,929 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $964,794 | 79,407 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $923,164 | 75,422 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $747,467 | 71,734 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $529,967 | 58,951 | Shares | Defined | 2021-08-11 | |
| 2020-09-30 | $14,134 | 27,182 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $20,658 | 27,182 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $174,861 | 171,434 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||